About 10 results found for searched term "65-46-3" (0.061 seconds)
Cat.No. | Name | Target |
---|---|---|
M5497 | Cefpiramide sodium | Antibiotic |
SM-1652; Wy-44635 | ||
Cefpiramide sodium (SM-1652; Wy-44635) is a new Pseudomonas-active cephalosporin with a broad spectrum of antibacterial activity. | ||
M5545 | Cytidine | DNA/RNA Synthesis |
Cytosine β-D-riboside; Cytosine-1-β-D-ribofuranoside | ||
Cytidine is a nucleoside molecule that is formed when cytosine is attached to a ribose ring, cytidine is a component of RNA. | ||
M7460 | URB 602 | Antibiotic |
URB602 is a selective monacylglycerol lipase (MGL) inhibitor with IC50 of 28±4 μM. | ||
M14208 | Endovion | Chloride Channel |
NS3728 | ||
Endovion (NS3728) is a pharmacological anion channel inhibitor (like chloride channel) and the specific VRAC/VSOAC blocker. Endovion (NS3728) is also an Anoctamin-1 (ANO 1) channel inhibitor. | ||
M24995 | Melrilimab | IL Receptor/Related |
GSK 3772847; CNTO-7160 | ||
Melrilimab (GSK 3772847) is an IgG2-kappa anti-IL1RL1/ST2/IL33R/DER4/FIT-1 monoclonal antibody. Melrilimab can be used for the research of asthma. | ||
M25134 | Lorigerlimab | PD-1/PD-L1 |
MGD019 | ||
Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting antibody (DART). Lorigerlimab can block PD-1 and CTLA-4, and improves T-cell responses. Lorigerlimab can be used for research of metastatic castration-resistant prostate cancer (mCRPC). | ||
M29531 | OICR12694 | Bcl-2 |
JNJ-65234637 | ||
OICR12694 (JNJ-65234637) is an orally active inhibitor of B cell lymphoma 6 (BCL6). | ||
M29532 | OICR12694 TFA | Bcl-2 |
JNJ-65234637 TFA | ||
OICR12694 (JNJ-65234637) TFA is an orally active inhibitor of B cell lymphoma 6 (BCL6). | ||
M50479 | 293P-1 | Others |
293P-1 is a peptide with tissue-specific homing properties. | ||
M56687 | Darexaban | Factor Xa |
Darexaban (YM150) is a potent, selective and orally active factor Xa (FXa) inhibitor with an IC50 of 54.6 nM. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.